Penalized partial likelihood regression for right-censored data with bootstrap selection of the penalty parameter

Biometrics

Volumn 58, Issue 4, 2002, Pages 781-791

  Huang, Jie ^a   Harrington, David ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cross validation; Model based bootstrap; Penalized partial likelihood; Penalty parameter; Proportional hazards model

Indexed keywords

HAZARDS; PARAMETER ESTIMATION; STATISTICAL METHODS;

COVARIATES; CROSS VALIDATION; ESTIMATION AND PREDICTIONS; MODEL-BASED BOOTSTRAP; MODEL-BASED OPC; PARTIAL LIKELIHOODS; PENALIZED PARTIAL LIKELIHOOD; PENALTY PARAMETERS; PROPORTIONAL HAZARD MODELS; RELATIVE RISKS;

RISK PERCEPTION;

BIOMETRY;

ARTICLE; COVARIANCE; DATA ANALYSIS; MATHEMATICAL ANALYSIS; MAXIMUM LIKELIHOOD METHOD; MULTIPLE MYELOMA; NONBIOLOGICAL MODEL; PENALIZED PARTIAL LIKELIHOOD REGRESSION; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; VALIDATION PROCESS;

EID: 0036968865     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0006-341X.2002.00781.x     Document Type: Article

References (29)

1. Allen, D. (1971). Mean squared error of prediction as a criterion for selecting variables. Technometrics 13, 469-475.
2. Andersen, P. and Gill, R. (1982). Cox's regression model for counting processes: A large sample study. Annals of Statistics 10, 1100-1120.
3. Copas, J. (1983). Regression, prediction, and shrinkage. Journal of the Royal Statistical Society, Series B 45, 311-354.
4. Crivelli, A., Firingguetti, L., Montaño, R., and Muñóz, M. (1995). Confidence intervals in ridge regression by bootstrapping the dependent variable: A simulation study. Communication in Statistics - Simulation 24, 631-652.
5. Davison, A. and Hinkley, D. (1997). Bootstrap Methods and Their Application. Cambridge, U.K.: Cambridge University Press.
6. Delaney, N. and Chatterjee, S. (1986). Use of the bootstrap and cross-validation in ridge regression. Journal of the American Statistical Association 4, 255-262.
7. Durie, B. and Salmon, S. (1975). A clinical staging system for multiple myeloma. Cancer 36, 842-854.
8. Fan, J. and Li, R. (2002). Variable selection for Cox's proportional hazards model and frailty model. Annals of Statistics 30, 74-99.
9. Faraggi, D. and Simon, R. (1998). Bayesian variable selection method for censored survival data. Biometrics 54, 1475-1485.
10. Fonseca, R., Harrington, D., Oken, M., Gordon, W., Bailey, R., Van Weir, S., Henderson, K., Blood, E., Rajkumar, S., Kay, N., Van Ness, B., and Greipp, P.R. (2002). Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (Δ13) in multiple myeloma: An Eastern Cooperative Oncology Group Study. Cancer Research 62, 715-720.
11. Frank, I. and Friedman, J. (1993). A statistical view of some chemometrics regression tools. Technometrics 35, 109-134.
12. Golub, G., Heath, M., and Wahba, G. (1979). Generalized cross-validation as a method for choosing a good ridge parameter. Technometrics 21, 215-223.
13. Gray, R. (1994). Spline-based tests in survival analysis. Biometrics 50, 640-652.
14. Hastie, T. and Tibshirani, R. (1990). Generalized Additive Models. London: Chapman and Hall.
15. Hoerl, A. and Kennard, R. (1970). Ridge regression: Biased estimation for nonorthogonal problems. Technometrics 12, 55-67.
16. Hoerl, A., Kennard, R., and Baldwin, K. (1975). Ridge regression: Some simulations. Communications in Statistics 4, 105-124.
17. Leblanc, M. and Crowley, J. (1999). Using the bootstrap for estimation in group sequential designs: An application to a clinical trial for nasopharangeal cancer. Statistics in Medicine 18, 2635-2644.
18. Liu, P., Leong, T., Quam, L., Billadeau, D., Kay, N., Greipp, P., Kyle, R., and Van Ness, B. (1996). Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: Analysis of the Eastern Cooperative Oncology Group Phase III trial. Blood 88, 2699-2706.
19. Miller, A. (1990). Subset Selection in Regression. London: Chapman and Hall.
20. Oken, M., Leong, T., Lenhard, R., Greipp, P., Kay, N., Van Ness, B., and Kyle, R. (1999). The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma. Cancer 86, 957-968.
21. O'Sullivan, F. (1988). Nonparametric estimation of relative risk using splines and cross-validation. SIAM Journal on Scientific and Statistical Computing 9, 531-542.
22. Raftery, A. and Volinsky, C. (1996). Accounting for model uncertainty in survival analysis improves predictive performance. Bayesian Statistics 5, 323-349.
23. Stein, C. (1956). Inadmissibility of the usual estimator for the mean of a multivariate distribution. Proceedings of the Third Berkeley Symposium on Mathematical Statistics and Probability 1, 197-206.
24. Tibshirani, R. (1997). The Lasso method for variable selection in the Cox model. Statistics in Medicine 16, 385-395.
25. Trendle, M., Leong, T., Kyle, R., Katzman, J., Oken, M., Kay, N., Van Ness, B., and Greipp, P. (1999). Prognostic significance of the s-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (clg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486. American Journal of Hematology 61, 232-237.
26. Verweij, P. and Van Houwelingen, H. (1993). Cross-validation in survival analysis. Statistics in Medicine 12, 2305-2314.
27. Verweij, P. and Van Houwelingen, H. (1994). Penalized likelihood in Cox regression. Statistics in Medicine 13, 2427-2436.
28. Vinod, H. (1995). Double bootstrap for shrinkage estimators. Journal of Econometrics 68, 287-302.
29. 2 type measure of dependence for proportional hazards models. Journal of Nonparametric Statistics 12, 83-107.